Respiratory syncytial virus (RSV) is a common germ that can settle into your lungs and airways. It's the top cause of upper respiratory infection in babies and toddlers, but anyone can get it. While ...

AJMC®: Respiratory syncytial virus (RSV) infection is often considered a childhood disease. Could you speak to this common conception and to the observed prevalence of RSV infection in adults? WALSH: ...

"…the present study highlights important differences in patient characteristics according to the virus involved. RSV and seasonal influenza are associated with more ...

Infant protection against respiratory syncytial virus (RSV) by maternal RSV vaccination or receipt of RSV monoclonal antibody ...

(CNN) — After Pope Francis was hospitalized last week for bronchitis, the Vatican has now announced that he has pneumonia in both lungs, with tests continuing to indicate a “complex clinical picture.” ...

Over 13 million adults aged 50-59 at increased risk in the US can potentially benefit from RSV immunization 1 RSV causes an estimated 42,000 hospitalizations* each year in adults aged 50-64 years old ...

Respiratory syncytial virus prefusion F (RSVpreF) vaccine significantly reduced severe RSV-related lower respiratory tract disease (LRTD) requiring hospitalization or emergency department (ED) visits ...

(CNN) — After Pope Francis was hospitalized last week for bronchitis, the Vatican announced that he remains in “critical” condition and suffered an “asthmatic respiratory crisis” on Saturday. (CNN) — ...

Tony Wood, Chief Scientific Officer, GSK: “We are pleased with ACIP's recommendation to expand the benefits of RSV immunization to more than 13 million adults aged 50-59 who are at increased risk for ...